Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Drug Stock Due for Another Climb on the Charts
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Teva Pharmaceutical Stock Could Double | Barron's
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva Stock Jumps Following Tentative Deal to Settle Opioid Cases | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva's Battered Stock Looks Extremely Cheap | Barron's
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's
Teva Stock Is Falling as an Analyst Says It Needs 'Numerous Litigation Wins' | Barron's
Teva - Updates, News, Events, Signals & Triggers
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Prosecutors Sue Teva's U.S. Business Over Charitable Donations - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
